NYSE · Healthcare · Biotechnology
Evommune, Inc.
EVMN
Evommune, Inc. CEO Luis C. Pena · Market cap $508.8M.
$14.02
+0.45 · +3.32%
52w hi $33.2052w lo $10.47
Off 52w high 60.1%
63
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
3 strong · 2 notable
Analyst consensus
Strong Buy
Avg PT $43.25
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jul 07 | Arthur S Kirsch | Buy | 10,000 | $13.30 | +$133K | 63 | |
| Nov 07 | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,157,096 | $16.00 | +$18.51M | 83 | |
| Nov 07 | LSP 7 Cooperative UA | Buy | 1,562,500 | $16.00 | +$25.00M | 80 | |
| Nov 07 | Weegen Felice Isabel Verduyn-Van | Buy | 1,562,500 | $16.00 | +$25.00M | 80 | |
| Nov 07 | RA CAPITAL MANAGEMENT, L.P. | Buy | 92,904 | $16.00 | +$1.49M | 73 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug